As the medical community continues to advance in both technology and technique, the importance of precise 12 lead ECG placement in diagnosing cardiovascular conditions has come into sharper focus.

While electrocardiograms are often the first test ordered to diagnose heart disease, they’re not as accurate as many think. Ennovea Medical is cutting down on electrode placement errors with a ...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of the industry’s first full-service, at-home, 12-lead ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, ...

A "quasi-standard" multilead ECG can be recorded using just the Apple Watch, a report showed. The ECG function on the Watch is designed to monitor electrical activity of the heart in the direction of ...

Department of Medical-Diagnostic Sciences, University of Padua, Padua, Italy Correspondence to Dr D Corrado, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, ...

Twelve-lead ECGs, although standard in hospitals, can be bulky and impractical for home use. On the other hand, Apple Watch’s ECG app is easy to use, but it is limited in what it can detect because it ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) clearance for its 12-lead ECG synthesis software for ...

FDA Clearance Granted After Successful Appeal, Overturning Prior Not Substantially Equivalent (NSE) Outcome HeartBeam’s Credit-Card Sized Device Delivers Clinical-Grade Insights Directly to Patients ...

Philips expands remote cardiac monitoring portfolio with patch-based, clinical-grade ECG designed to improve patient recruitment, compliance and retention by reducing need for site visits during ...